IMNN logo

IMNN Imunon, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$1.65
+0.07 (+4.43%)

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently…

Market Cap: $6.93Mwww.imunon.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
120
Aug 11Aug 11

Quote

Day Range
$1.58 – $1.67
52-Week Range
$1.47 – $6.96
Volume
$55.3K
Market Cap
$6.93M
50-Day Avg
$1.79
200-Day Avg
$2.93
Prev Close
$1.58
Open
$1.58

Valuation & Ratios

P/E Ratio
-0.56
EPS
$-6.83
P/B Ratio
1.15
P/S Ratio
0.00
Debt/Equity
0.14
Current Ratio
2.32
Dividend Yield
+0.1%
Gross Margin
+0.0%

Returns & Efficiency

Return on Equity
-205.3%
Return on Assets
-118.0%
FCF Yield
-175.3%
EV/EBITDA
-0.02

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$0.00$-14.49M$-6.83
2024$0.00$-18.62M$-21.10
2023$0.00$-19.51M$-28.14
2022$500.0K$-35.90M$-65.55
2021$500.0K$-20.77M$-748.77

Social Signal Score

70
5d
70
1 mentions
30d
70
1 mentions
60d
70
1 mentions
90d
70
1 mentions
news: 1

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $-0.72 per share

7of 7 quarters beat consensus

Typical surprise +32.9% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Aug 11$-0.54 vs $-0.87beat
  • Tue, May 12$-0.84 vs $-1.22beat
  • Tue, Mar 31$-1.29 vs $-1.43beat
  • Thu, Nov 13$-1.16 vs $-1.73beat
  • Tue, Aug 5$-1.87 vs $-3.09beat
  • Mon, May 12$-3.65 vs $-4.56beat

Estimates and results for IMNN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

IMNNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsseekingalpha.com·3d ago·Positive

    Imunon, Inc. (IMNN) Q2 2026 Earnings Call Transcript Imunon, Inc. (IMNN) Q2 2026 Earnings Call Transcript

    View source ↗